Scholarlink

Background <p>Tfh cells play a crucial role in the pathogenesis of SLE. Our previous research confirmed that SETD3, which is upregulated in CD4<sup>+</sup> T cells of SLE patients, mediates the overexpression of CXCR5 by upregulating the CXCR5 promoter histones H3K4me3 and H3K36me3. However, the recent study demonstrates that SETD3, in contrast to other protein lysine methyltransferases, does not methylate histones; its sole verified substrate is H73 of actin. Consequently, the molecular mechanism by which SETD3 influences histone methylation requires further investigation. The most important transcription factor in the development and differentiation of Tfh cells is Bcl-6. Whether SETD3 can directly participate in the regulation of Tfh cell differentiation by regulating the expression of Bcl-6 remains to be further studied.</p> Results <p>Our results demonstrated that SETD3 maintained a high level of expression throughout the differentiation process of Tfh cells. Moreover, following the interference with SETD3 expression, the expression of Bcl-6 and the differentiation of Tfh cells were notably impeded. SETD3 mediates the H3K4me3/K36me3 and H3K9ac/K14ac modifications of Bcl-6 promoter by interacting with NSD3, SMYD2, p300 and CBP, thereby upregulating Bcl-6 expression in Tfh differentiation. In addition, we also confirmed that the levels of H3K4me3/K36me3 and H3K9ac/K14ac in Bcl-6 promoter of SLE CD4<sup>+</sup> T cells were significantly higher than those of healthy controls, which was related to SETD3 mediated upregulation of NSD3, SMYD2, p300 and CBP binding to Bcl-6 promoter. Inhibiting SETD3 expression in CD4<sup>+</sup> T cells from SLE patients effectively reduces the levels of H3K4me3/K36me3, and H3K9ac/K14ac at the Bcl-6 promoter, thereby downregulating Bcl-6 expression.</p> Conclusions <p>Elevated SETD3 expression in SLE CD4<sup>+</sup> T cells recruits NSD3, SMYD2, p300, and CBP to the Bcl-6 promoter, thus upregulating histone H3K4/K36 methylation and H3K9/K14 acetylation at this locus, which mediates the upregulation of Bcl-6 expression.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

SETD3 regulates Bcl-6 expression and Tfh differentiation in SLE CD4+ T cells by manipulating histone methylation and acetylation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月21日

查看全文
  • Shu Ding,
  • Shengjie Xue,
  • Yu Rao,
  • Ling-xue Hu,
  • Jie-yue Liao

摘要

Background

Tfh cells play a crucial role in the pathogenesis of SLE. Our previous research confirmed that SETD3, which is upregulated in CD4+ T cells of SLE patients, mediates the overexpression of CXCR5 by upregulating the CXCR5 promoter histones H3K4me3 and H3K36me3. However, the recent study demonstrates that SETD3, in contrast to other protein lysine methyltransferases, does not methylate histones; its sole verified substrate is H73 of actin. Consequently, the molecular mechanism by which SETD3 influences histone methylation requires further investigation. The most important transcription factor in the development and differentiation of Tfh cells is Bcl-6. Whether SETD3 can directly participate in the regulation of Tfh cell differentiation by regulating the expression of Bcl-6 remains to be further studied.

Results

Our results demonstrated that SETD3 maintained a high level of expression throughout the differentiation process of Tfh cells. Moreover, following the interference with SETD3 expression, the expression of Bcl-6 and the differentiation of Tfh cells were notably impeded. SETD3 mediates the H3K4me3/K36me3 and H3K9ac/K14ac modifications of Bcl-6 promoter by interacting with NSD3, SMYD2, p300 and CBP, thereby upregulating Bcl-6 expression in Tfh differentiation. In addition, we also confirmed that the levels of H3K4me3/K36me3 and H3K9ac/K14ac in Bcl-6 promoter of SLE CD4+ T cells were significantly higher than those of healthy controls, which was related to SETD3 mediated upregulation of NSD3, SMYD2, p300 and CBP binding to Bcl-6 promoter. Inhibiting SETD3 expression in CD4+ T cells from SLE patients effectively reduces the levels of H3K4me3/K36me3, and H3K9ac/K14ac at the Bcl-6 promoter, thereby downregulating Bcl-6 expression.

Conclusions

Elevated SETD3 expression in SLE CD4+ T cells recruits NSD3, SMYD2, p300, and CBP to the Bcl-6 promoter, thus upregulating histone H3K4/K36 methylation and H3K9/K14 acetylation at this locus, which mediates the upregulation of Bcl-6 expression.